tranexamic acid has been researched along with misoprostol in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (7.69) | 29.6817 |
| 2010's | 5 (38.46) | 24.3611 |
| 2020's | 7 (53.85) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Arakawa, T; Sugimori, S; Watanabe, T | 1 |
| Hofmeyr, GJ; Qureshi, Z | 1 |
| Lalonde, A; Weeks, AD | 1 |
| Abbas, AM; Abdelkader, AM; Alanwar, A; Ali, SS; Elsayed, AH; Sallam, HF; Shady, NW | 1 |
| Beaumont, D; Gayet-Ageron, A; Ker, K; Mousa, HA; Pavord, S; Shakur, H | 1 |
| Abbas, D; Diop, A; Martin, R; Ngoc, NTN; Razafi, A; Tuyet, HTD; Winikoff, B | 1 |
| Angarita, AM; Berghella, V | 1 |
| Allott, H; Ameh, CA; Dickinson, F; Godia, P; Meka, RJ; West, F | 1 |
| Eke, AC; Federspiel, JJ; Jones, AJ | 1 |
| Anikwe, CC; Dimejesi, OB; Esike, CO; Ikeoha, CC; Ogah, CO; Okorochukwu, BC | 1 |
| Abdel-Rasheed, M; Al-Husseiny, M; Dawoud, M; Elsherbini, M; Helal, O; Sediek, M | 1 |
| Abdulmalik, NA; Abu-Zaid, A; Abuzaid, M; Albadawi, MI; Alblewi, H; Albouq, B; Alomar, O; Alsehaimi, SO; Alyousef, A; Baradwan, S; Bukhari, IA; Ghazi, A; Khadawardi, K; Salem, H | 1 |
6 review(s) available for tranexamic acid and misoprostol
| Article | Year |
|---|---|
[Side effects of gastric muco-protective agents].
Topics: Adjuvants, Pharmaceutic; Alanine; Alprostadil; Aluminum; Anti-Ulcer Agents; Diterpenes; Drug Interactions; Gastric Acid; Gastric Emptying; Humans; Hydrogen-Ion Concentration; Misoprostol; Quinolones; Sulpiride; Tranexamic Acid | 2007 |
Preventing deaths due to haemorrhage.
Topics: Abruptio Placentae; Antifibrinolytic Agents; Blood Transfusion; Cesarean Section; Crystalloid Solutions; Ergonovine; Female; Fluid Therapy; Gravity Suits; Health Facilities; Home Childbirth; Humans; Hysterectomy; Isotonic Solutions; Labor, Induced; Massage; Maternal Death; Misoprostol; Oxytocics; Oxytocin; Placenta Previa; Postpartum Hemorrhage; Pregnancy; Tourniquets; Tranexamic Acid; Uterine Artery Embolization; Uterine Balloon Tamponade; Uterine Hemorrhage; Uterine Rupture | 2016 |
Antifibrinolytic drugs for treating primary postpartum haemorrhage.
Topics: Antifibrinolytic Agents; Cause of Death; Female; Humans; Maternal Mortality; Misoprostol; Postpartum Hemorrhage; Pregnancy; Randomized Controlled Trials as Topic; Tranexamic Acid | 2018 |
Evidence-based labor management: third stage of labor (part 5).
Topics: Female; Humans; Infant, Newborn; Lacerations; Methylergonovine; Misoprostol; Oxytocics; Oxytocin; Placenta; Postpartum Hemorrhage; Pregnancy; Tranexamic Acid | 2022 |
Preventing postpartum hemorrhage with combined therapy rather than oxytocin alone.
Topics: Female; Humans; Methylergonovine; Misoprostol; Oxytocics; Oxytocin; Postpartum Hemorrhage; Pregnancy; Tranexamic Acid | 2023 |
Tranexamic acid versus misoprostol for management of postpartum hemorrhage: A systematic review and meta-analysis of randomized controlled trials.
Topics: Antifibrinolytic Agents; Blood Loss, Surgical; Female; Hemostatics; Humans; Misoprostol; Postpartum Hemorrhage; Pregnancy; Randomized Controlled Trials as Topic; Tranexamic Acid | 2023 |
4 trial(s) available for tranexamic acid and misoprostol
| Article | Year |
|---|---|
The effect of prophylactic oral tranexamic acid plus buccal misoprostol on blood loss after vaginal delivery: a randomized controlled trial.
Topics: Adult; Antifibrinolytic Agents; Female; Humans; Misoprostol; Oxytocics; Postpartum Hemorrhage; Pregnancy; Tranexamic Acid; Young Adult | 2019 |
A double-blind, randomized controlled trial to explore oral tranexamic acid as adjunct for the treatment for postpartum hemorrhage.
Topics: Adolescent; Adult; Antifibrinolytic Agents; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Middle Aged; Misoprostol; Oxytocics; Postpartum Hemorrhage; Pregnancy; Tranexamic Acid; Young Adult | 2020 |
A randomised controlled trial of tranexamic acid versus misoprostol in reducing blood loss during caesarean section.
Topics: Blood Loss, Surgical; Cesarean Section; Female; Humans; Misoprostol; Oxytocics; Oxytocin; Pregnancy; Tranexamic Acid | 2022 |
Intravenous tranexamic acid vs. sublingual misoprostol in high-risk women for postpartum haemorrhage following cesarean delivery; a randomised clinical trial.
Topics: Blood Loss, Surgical; Cesarean Section; Female; Humans; Misoprostol; Oxytocin; Postoperative Hemorrhage; Postpartum Hemorrhage; Pregnancy; Tranexamic Acid | 2023 |
3 other study(ies) available for tranexamic acid and misoprostol
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Moving Beyond Uterotonics for the Treatment of Postpartum Hemorrhage: Lessons From the WOMAN Study.
Topics: Antifibrinolytic Agents; Blood Transfusion; Female; Hemostatic Techniques; Humans; Hysterectomy; Misoprostol; Oxytocics; Oxytocin; Postpartum Hemorrhage; Pregnancy; Tranexamic Acid | 2017 |
A synthesis of clinical and health system bottlenecks to implementing new WHO postpartum hemorrhage recommendations: Secondary data analysis of the Kenya Confidential Enquiry into Maternal Deaths 2014-2017.
Topics: Data Analysis; Female; Humans; Kenya; Maternal Death; Misoprostol; Oxytocics; Postpartum Hemorrhage; Pregnancy; Retrospective Studies; Tranexamic Acid; World Health Organization | 2022 |